Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerald P Radich

Showing results (11-20 of 208) with videos related to

Pageof 21
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|May 27, 2016
Management of Advanced-Phase Chronic Myelogenous LeukemiaJerald P Radich
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 19, 2008
Molecular classification of acute myeloid leukemia: are we there yet?Jerald P Radich
Therapeutic Advances in Hematology|April 5, 2013
Allogeneic transplant for chronic myeloid leukemia in 2010Jerald P Radich
Biochimica Et Biophysica Acta|April 19, 2002
The promise of gene expression analysis in hematopoetic malignanciesJerald P Radich
Clinical Advances in Hematology & Oncology : H&O|September 30, 2008
Monitoring treatment results in patients with chronic myelogenous leukemiaJerald P Radich
Blood|August 8, 2009
How I monitor residual disease in chronic myeloid leukemiaJerald P Radich
Cancer|July 1, 2011
Measuring response to BCR-ABL inhibitors in chronic myeloid leukemiaJerald P Radich
Hematology/Oncology Clinics of North America|November 8, 2011
The biology of chronic myelogenous leukemia progression: who, what, where, and why?Jerald P Radich
Blood|March 24, 2018
There is nothing minimal about residual diseaseJerald P Radich
Haematologica|March 1, 2022
Another Philadelphia storyJerald P Radich
Pageof 21

Showing results (11-20 of 208) with videos related to

Sort By:
Pageof 21
Journal of the National Comprehensive Cancer Network : JNCCN|May 27, 2016
Management of Advanced-Phase Chronic Myelogenous LeukemiaJerald P Radich
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 19, 2008
Molecular classification of acute myeloid leukemia: are we there yet?Jerald P Radich
Therapeutic Advances in Hematology|April 5, 2013
Allogeneic transplant for chronic myeloid leukemia in 2010Jerald P Radich
Biochimica Et Biophysica Acta|April 19, 2002
The promise of gene expression analysis in hematopoetic malignanciesJerald P Radich
Clinical Advances in Hematology & Oncology : H&O|September 30, 2008
Monitoring treatment results in patients with chronic myelogenous leukemiaJerald P Radich
Blood|August 8, 2009
How I monitor residual disease in chronic myeloid leukemiaJerald P Radich
Cancer|July 1, 2011
Measuring response to BCR-ABL inhibitors in chronic myeloid leukemiaJerald P Radich
Hematology/Oncology Clinics of North America|November 8, 2011
The biology of chronic myelogenous leukemia progression: who, what, where, and why?Jerald P Radich
Blood|March 24, 2018
There is nothing minimal about residual diseaseJerald P Radich
Haematologica|March 1, 2022
Another Philadelphia storyJerald P Radich
Pageof 21